Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2009

01-01-2009 | Original Paper

Incidence of Predominant Methanogenic Flora in Irritable Bowel Syndrome Patients and Apparently Healthy Controls from North India

Authors: S. V. Rana, S. Sharma, S. K. Sinha, H. Kaur, A. Sikander, K. Singh

Published in: Digestive Diseases and Sciences | Issue 1/2009

Login to get access

Abstract

Background Flatulence is a common symptom in patients with irritable bowel syndrome (IBS). This may be due to production of hydrogen by intestinal flora. With the presence of methanogenic flora, 4 mol of hydrogen (H2) are used with 1 mol of carbon dioxide (CO2) to produce 1 mol of methane (CH4), a process greatly reducing the volume of gas in the colon. However, the prevalence of methanogenic flora has not yet been reported in healthy and IBS patients from North India. Therefore, this study was planned. Methods This study was conducted prospectively and included 345 patients with irritable bowel syndrome (fulfilling Rome II criteria) and 254 age- and gender-matched apparently healthy controls. Each subject underwent a hydrogen breath test using 10 g lactulose after an overnight fast. An SC Microlyser from Quintron, USA, was used to measure methane and hydrogen at baseline and at every 30 min for 4 h. Subjects with fasting methane concentration <10 p.p.m. were labeled as low methane producers (LMPs) and > 10 p.p.m. as predominant methane producers (PMPs). Results The IBS and control groups included 66.78% and 67.53% men, respectively. Mean age in the two groups was 48.52 ± 30.54 years (range 15–68 years) and 45.67 ± 30.54 years (range 15–78 years), respectively. Prevalence of predominant methanogenic flora in IBS and control groups was 14.5% (50/345) and 34.6% (88/254), respectively (P < 0.001). Fifty-two out of 254 (20.6 %) were PMPs and 36 out of 254 (14.0%) were LMPs in controls. In contrast to this, IBS patients had 17 out of 354 (4.9%) that were PMPs and 33 out of 345 (9.6%) that were LMPs. Conclusion Methanogenic flora was significantly lower in IBS patients from North India than in apparently healthy subjects. This may be one of the causes of flatulence in IBS patients.
Literature
5.
6.
go back to reference Myo-Khin, Bolin TD, Khin-Mar-Oo, Tin-Oo, Kyaw-Hla S, Thein-Myint T (1999) Ineffectiveness of breath methane excretion as a diagnostic test for lactose malabsorption. J Pediatr Gastroenterol Nutr 28:474–479. doi:10.1097/00005176-199905000-00006 Myo-Khin, Bolin TD, Khin-Mar-Oo, Tin-Oo, Kyaw-Hla S, Thein-Myint T (1999) Ineffectiveness of breath methane excretion as a diagnostic test for lactose malabsorption. J Pediatr Gastroenterol Nutr 28:474–479. doi:10.​1097/​00005176-199905000-00006
7.
8.
go back to reference Corazza GR, Benati G, Strocchi A, Malservisi S, Gasbarrini G (1994) The possible role of breath methane measurement in detecting carbohydrate malabsorption. J Lab Clin Med 124:695–700PubMed Corazza GR, Benati G, Strocchi A, Malservisi S, Gasbarrini G (1994) The possible role of breath methane measurement in detecting carbohydrate malabsorption. J Lab Clin Med 124:695–700PubMed
9.
go back to reference Bond JH, Levitt MD (1997) Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med 90:30–36 Bond JH, Levitt MD (1997) Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med 90:30–36
10.
go back to reference Bond JH Jr, Engel RR, Levitt MD (1971) Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria. J Exp Med 133:572–588. doi:10.1084/jem.133.3.572 PubMedCrossRef Bond JH Jr, Engel RR, Levitt MD (1971) Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria. J Exp Med 133:572–588. doi:10.​1084/​jem.​133.​3.​572 PubMedCrossRef
12.
go back to reference Peled Y, Weinberg D, Hallak A, Gilat T (1987) Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci 32(3):267–271. doi:10.1007/BF01297052 PubMedCrossRef Peled Y, Weinberg D, Hallak A, Gilat T (1987) Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci 32(3):267–271. doi:10.​1007/​BF01297052 PubMedCrossRef
15.
go back to reference Piqué JM, Pallarés M, Cusó E, Vilar-Bonet J, Gassull MA (1984) Methane production and colon cancer. Gastroenterology 87:601–605PubMed Piqué JM, Pallarés M, Cusó E, Vilar-Bonet J, Gassull MA (1984) Methane production and colon cancer. Gastroenterology 87:601–605PubMed
Metadata
Title
Incidence of Predominant Methanogenic Flora in Irritable Bowel Syndrome Patients and Apparently Healthy Controls from North India
Authors
S. V. Rana
S. Sharma
S. K. Sinha
H. Kaur
A. Sikander
K. Singh
Publication date
01-01-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0315-x

Other articles of this Issue 1/2009

Digestive Diseases and Sciences 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.